Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

A better direction

Could behavioural science be the key to improving patient outcomes?

- PMLiVE

M&A is now vital to pharma – but it’s vital to get it right

Numbers speak louder than words when it comes to explaining why the concept of mergers and acquisitions (M&A) is newly significant for the pharma industry. The value of deals that...

- PMLiVE

AbbVie pays $595m upfront for Boehringer psoriasis drug

Says BI 655066 has the potential to become a ‘best-in-class’ treatment

- PMLiVE

Sanofi and Merck & Co dissolve longstanding vaccines alliance

Lacklustre sales at Sanofi Pasteur MSD prompts split

- PMLiVE

The growing necessity for pharma to become a true health delivery partner of the NHS

Focus on solving your customer’s biggest problems to create shared value

- PMLiVE

Why don’t big pharma brands win creative awards?

There’s a striking lack of correlation between commercial and creative success

- PMLiVE

Who don’t need no education?

It’s time pharma rebelled against its own risk-averse traditions

Pegasus shortlisted for four PM Society Digital Media Awards 2016

Pegasus, the UK’s leading independent health communications consultancy, has had recognition of its work in digital media with shortlistings for four awards at the PM Society Digital Media Awards 2016...

Inizio

The new EU clinical trial lay summaries

New regulations will require both a trial summary and a lay person’s summary

- PMLiVE

The new EU clinical trial lay summaries

New regulations will require both a trial summary and a lay person’s summary

- PMLiVE

Genital herpes vaccine candidate promising in phase II

Genocea Biosciences’ GEN-003 found to reduce recurrence and transmission of the virus

- PMLiVE

European sites

What makes a country in Europe attractive to life science companies?

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links